Beryllium metal has physical properties that make its use essential for very specific applications, such as medical diagnostics, nuclear/fusion reactors and aerospace applications. Because of the widespread human exposure to beryllium metals and the discrepancy of the genotoxic results in the reported literature, detail assessments of the genetic damage of beryllium are warranted. Mice exposed to beryllium chloride at an oral dose of 23 mg/kg for seven consecutive days exhibited a significant increase in the level of DNAstrand breaking and micronuclei formation as detected by a bone marrow standard comet assay and micronucleus test. Whereas slight beryllium chloride-induced oxidative DNA damage was detected following formamidopyrimidine DNA glycosylase digestion, digestion with endonuclease III resulted in considerable increases in oxidative DNA damage after the 11.5 and 23 mg/kg/day treatment as detected by enzyme-modified comet assays. Increased 8-hydroxydeoxyguanosine was also directly correlated with increased bone marrow micronuclei formation and DNA strand breaks, which further confirm the involvement of oxidative stress in the induction of bone marrow genetic damage after exposure to beryllium chloride. Gene expression analysis on the bone marrow cells from beryllium chloride-exposed mice showed significant alterations in genes associated with DNA damage repair. Therefore, beryllium chloride may cause genetic damage to bone marrow cells due to the oxidative stress and the induced unrepaired DNA damage is probably due to the down-regulation in the expression of DNA repair genes, which may lead to genotoxicity and eventually cause carcinogenicity.
Introduction
Beryllium metal has physical properties that make its use essential for very specific applications, such as medical diagnostics, nuclear/fusion reactors, golf clubs and aerospace applications (1) . Workers are exposed to beryllium-containing dusts during the crushing and grinding of ores, and to soluble beryllium salts during extraction of the metal from ore and in the processing of beryllium metal and alloys (2) . In the general population, tobacco smoking is probably a major source of beryllium exposure (3) . Burning of coal is also considered to be an important source of environmental exposure to beryllium (4) . In addition, oral intake of beryllium through drinking water represents a route of human exposure to this metal as beryllium has been detected in surface water and groundwater. The mean of beryllium content (µg/kg) in drinking water was <0.6 in Spain, <0.1 in the USA, 0.008 in Germany and 1.24 in Saudi Arabia (5) . Occupational exposure to beryllium and beryllium compounds is associated with increased lung cancer mortality and exposure to beryllium metal, beryllium oxide and beryllium salts caused lung tumours in rats and rhesus monkeys (6) .
It seems possible that the carcinogenicity of beryllium salts may be operating through a genotoxic mode of action; however, the existing studies on genotoxicity of beryllium salts have yielded inconclusive results. In bacterial assays, beryllium salts were not mutagenic (7) , whereas in the majority of investigations with mammalian cells, beryllium salts induced sister chromatid exchanges, chromosomal aberrations and gene mutations (8) . Dose-dependent increases in sister chromatid exchanges were also observed in both beryllium chloride (BeCl 2 )-and beryllium nitrate-exposed V79 cells (9) . Moreover, it was found that beryllium induced morphological cell transformation in mammalian cells (BALB/c3T3) and that these transformed cells were potentially tumourigenic (10) . In vitro micronucleus testing in Syrian hamster embryo cells was positive for soluble compounds (11) , while oral exposure to beryllium sulphate did not increase the incidence of micronucleated bone marrow cells in vivo (12) . On the other hand, Nikiforova and Voronin (13) found that small doses of beryllium given to rats via drinking water for long periods induced a significant percentage of chromosomal aberrations in bone marrow cells. A previous study reported that BeCl 2 is a somatic and germ-cell genotoxic agent capable of inducing structural chromosome aberrations in mice (14) .
Because of the widespread human exposure to beryllium, the importance of beryllium in many industrial applications and the discrepancy of the results in the reported literature, detail assessments of the genetic damage of beryllium are warranted. Such assessments are essential since the genetic damage, particularly in the population of undifferentiated cells that constitutes bone marrow, is dangerous because it can lead to mutations and DNA rearrangements. If such cells survive and proliferate, the risk of secondary acute myeloid leukaemia and other drug-related cancers can increase. In this study, the assessment was achieved through the in vivo micronucleus test and comet assay. The biochemical alteration characteristic of oxidative DNA damage induced by beryllium such as 8-hydroxy-2′-deoxyguanosine (8-OHdG) has been evaluated. In addition, quantitative analysis of mRNA expression of the DNA repair-related genes was performed by real-time reverse polymerase chain reaction (RT-PCR).
Materials and methods

Animals
Adult male white Swiss albino mice, weighing 20-25 g (10-12 weeks old), were obtained from Experimental Animal Care Center, College of Pharmacy, King Saud University. The animals were maintained under standard conditions of humidity, temperature (25 ± 2°C) and light (12-h light/12-h dark). They were fed with a standard mice pellet diet and had free access to water. The maintenance, handling, treatment and sacrifice of animals were approved by the Ethics Committee of the Experimental Animal Care Society, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Each treatment group and control group consisted of five randomly assigned animals. The total number of animals in this study was 90 treated mice and 30 vehicle controls.
Chemicals and treatments
BeCl 2 (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) was dissolved in saline and administered by a single oral administration (using a stomach tube) once a day for 7 consecutive days. The positive control group was injected intraperitoneally with mitomycin C (Sigma-Aldrich Chemie GmbH, Steinheim) at a dose of 2 mg/kg in saline 24 h before being killed, whereas the negative control group received saline only.
Micronucleus test
BeCl 2 was investigated in two separate experiments. In the first experiment, animals were orally treated with single doses of 5.75, 11.5 or 23 mg/kg (1/12, 1/8 and 1/4 of the experimental oral LD 50 in mice) of BeCl 2 and bone marrow cells were sampled 24 h after treatment. Preliminary negative micronuclei (MN) results from single treatment (data not shown) led to the use of repeated exposures to BeCl 2 . Thus, in the second experiment, mice were treated with 5.75, 11.5 or 23 mg/kg/day of BeCl 2 for 7 consecutive days (to cover the seven cell divisions of erythropoiesis) and bone marrow cells were sampled 24 h after the last treatment. The animals tolerated the highest dose without any toxic symptoms. The animals became sluggish after treatment but recovered within 2 h of the treatment. Bone marrow cells were collected from both femurs in tubes containing foetal calf serum and bone marrow smears were prepared and stained with May-Grunwald/Giemsa as described previously (15) . At least two slides were made for each animal and allowed to dry overnight. Per animal, 2000 polychromatic erythrocytes (PCEs) of coded slides were scored for the presence of MN. Bone marrow suppression was also determined as described previously (16) .
Comet assays
In the time-course experiments, the animals were euthanised at 3 and 24 h following the last treatments with 5.75, 11.5 or 23 mg/kg/day BeCl 2 for 7 consecutive days. The 3-h time point was chosen to maximise the chances of detecting an early genotoxic response to the BeCl 2 treatment. Upon sacrifice, the bone marrow cells were collected and the standard comet assay was performed as previously described (17) . Four slides were prepared for each animal; 50 cells were selected randomly from each slide and scored using a system consisting of Nikon fluorescent microscope and TriTek CometScore digital imaging software. The extent of DNA damage can be quantified using this sensitive technique, with the most frequently reported measure being the olive tail moment [OTM = (Tail mean − Head mean) × Tail% DNA/100].
DNA repair enzymes treatment
For detecting oxidative DNA damage, the modified comet assay using lesionspecific enzymes were also used on parallel slides to detect oxidised purines and pyrimidines. Cells were embedded in agarose on microscope slides and stored in the lysis buffer as previously described (17) . After lysing, the slides were washed three times for 5 min each with an enzyme buffer (40 mM HEPES, 0.1 M potassium chloride, 0.5mM EDTA, 0.2 mg/ml bovine serum albumin, with the solution adjusted to pH 8.0 with potassium hydroxide). After washing, excess liquid was removed and 50 µl of the following solutions were applied to slides prepared from each treatment group: enzyme buffer alone (reference slides), enzyme buffer containing formamidopyrimidine DNA glycosylase (Fpg, which catalyses excision of oxidised purines) and enzyme buffer containing endonuclease III (EndoIII, which catalyses excision on oxidised pyrimidines). The slides were kept in a moist box and incubated at 37°C for 45 min. After the enzyme treatment, the slides were placed in a horizontal electrophoresis chamber to perform DNA unwinding, then electrophoresis and slide staining were the same as mentioned previously (17) . Thereafter, slides were scored as described previously for the standard comet assay. Oxidative DNA-damage calculation was based on the method described in the protocol by Dusinska (18) . Briefly, the control gels (reference slides) provide an estimate of the background of DNA strand breaks. The enzyme-treated gels reveal strand breaks and oxidised bases (strand breaks + oxidised bases). Assuming a linear dose-response while using OTM or other arbitrary units, subtraction of strand breaks from strand breaks + oxidised bases gives a measure of oxidised pyrimidines/altered purines.
Estimation of serum DNA 8-OHdG
The amounts of 8-OHdG at 3 and 24 h after the last treatment with 5.75, 11.5 or 23 mg/kg/day BeCl 2 for 7 consecutive days in serum were determined using the Bioxytech 8-OHdG-ELISA Kit (OXIS Health Products, Portland, OR) as previously described (19) . Reported values are the average of triplicate determinations and serum levels of 8-OHdG are expressed as nanogram per millilitre.
Gene expression analyses
Quantitative analysis of mRNA expression of DNA damage and repair-related genes such as 8-oxoguanine-DNAglycosylase (OGG1), apurinic/apyrimidinic endonuclease 1 (Apex1), X-ray repair complementing defective repair in Chinese hamster cells 1 (XRCC1), PARP1 and p53 was performed by RT-PCR to estimate the gene expression levels after treatment. Bone marrow cells were collected from mice treated with 23 mg/kg/day BeCl 2 for 7 days or vehicle control, which were harvested 3 and 24 h after the last treatments. Total RNA from bone marrow cells was isolated using TRIzol reagent (Invitrogen®) according to the manufacturer's instructions and quantity and quality of the RNA were determined with a NanoDrop 8000. Thereafter, first-strand complementary (cDNA) synthesis was performed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems
Quantitative analysis of specific mRNA expression was performed by subjecting the resulting cDNA to PCR amplification using 96-well optical reaction plates in the ABI Prism 7500 System (Applied Biosystems®). The 25-µl reaction mixture contained 0.1 µl of 10 µM forward primer and 0.1 µl of 10 µM reverse primer (40 nM final concentration of each primer), 12.5 µl of SYBR Green Universal Mastermix, 11.05 µl of nuclease-free water and 1.25 µl of cDNA sample. The primers that were used in this study are shown in Table I . The RT-PCR data were analysed using the relative gene expression (i.e. ΔΔ CT) method (20) . The cycle threshold (CT) is defined as the number of cycles required for the fluorescent signal to cross the threshold line (i.e. exceeds background level). The levels of mRNA, normalised to that of the Cyclophilin A gene, were calculated. The data represent the average fold changes with standard errors.
Statistical analysis
Cytogenetic data were analysed by the non-parametric test, Kruskal-Wallis test and Mann-Whitney U-test. Data on oxidative DNA stress and expression analysis were analysed by analysis of variance and unpaired t-test using software computer program (GraphPad InStat; DATASET1.ISD). Results were considered significantly different if the P < 0.05.
Results and discussion
Beryllium has physical-chemical properties, including low density and high tensile strength, which make it useful in the manufacture of a wide range of products. Despite its utility, a number of standard setting agencies have determined that beryllium is a carcinogen. Only a limited number of studies, however, have addressed the underlying mechanisms of the carcinogenicity of beryllium. Importantly, mutation and chromosomal aberration assays have yielded somewhat contradictory results for beryllium compounds and whereas bacterial tests were largely negative, mammalian test systems showed evidence of beryllium-induced mutations, chromosomal aberrations and cell transformation (8) . The data of this study demonstrate that BeCl 2 is a genotoxic agent and the genotoxicity induced by BeCl 2 revealed that BeCl 2 could exert dose-dependent genotoxic effects. Moreover, BeCl 2 may cause DNA damage to bone marrow cells due to the oxidative stress and the induced DNA damage was unrepaired due to the decreased activity of some DNA repair genes. The micronucleus test has been widely used to measure unrepaired genome damage and increased MN frequency predicts the risk of cancer in humans (21) . Results of micronucleus test in bone marrow cells of mice treated with different doses of BeCl 2 or the negative and positive controls are shown in Figure 1 . A statistically significant increase in the incidence of micronucleated polychromatic erythrocytes (MNPCE) over the control value was observed following treatment with the positive control substance mitomycin C. These results are in harmony with the in vivo positive results reported earlier for mitomycin C in the mouse bone marrow micronucleus test (22) and confirm the sensitivity of the experimental protocol followed in the detection of genotoxic effects of chemicals. Treatment of mice with 5.75 and 11.5 mg/kg/day of BeCl 2 for 7 consecutive days did not induce any significant increase in frequency of MNPCE compared with the control group. On the other hand, the 23 mg/kg/day treatment for 7 days induced a significant increase in the frequency of MNPCE compared with the control value. This genetic damage, particularly in the population of undifferentiated cells that constitutes bone marrow, is dangerous because it can lead to mutations and DNA rearrangements. If such cells survive and proliferate, the risk of secondary acute myeloid leukaemia and other drugrelated cancers can increase. BeCl 2 did not cause any suppression of erythroblast proliferation at the all tested doses and the percent of PCE was nearly similar in all groups (data not shown). Since the micronucleus test has been widely used to measure unrepaired genomic damage, the observed positive response could be indicative of the DNA damage that was unrepaired and that this may be one of its carcinogenic modes of action. Our results are in agreement with previously published data reported in other in vivo studies (13, 14) , indicating a significant effect of beryllium on animal bone marrow chromosomes. The resulting in vivo data also confirm the earlier in vitro findings for beryllium ions in which significant increases in the amount of sister chromatid exchanges and chromosomal aberrations were found in cultured mammalian cells (23, 24) .
In the present standard comet assay, a statistically significant increase in the incidence of OTM over the control value was observed following treatment with the positive control substance mitomycin C at 24-h sampling time (Figure 2) . Treatment of mice with 23 mg/kg/day of BeCl 2 for 7 days induced significant increases in OTM compared with the control groups at 3-and 24-h sampling times. Moreover, a significant increase in OTM was also observed at 3-h sampling time after the last treatment with 11.5 mg/kg/day of BeCl 2 . In general, the response was higher at 3 h after treatment than at 24 h, suggesting that there was a time-dependent reduction in DNA damage, which may also suggest a time-dependent DNAdamage repair. The types of DNA damages (such as oxidative DNA damage) being detected by comet assay can be expanded by incubating the lysed cells with lesion-specific endonucleases that recognise specific damaged bases and create breaks (25, 26) . In this study, Fpg-and EndoIII-modified comet assays were performed in parallel with the standard comet assay. These two endonucleases are used in the comet assay to detect oxidative DNA damage: EndoIII detects damaged pyrimidine bases, whereas Fpg recognises oxidised purines. In this study, digestion with EndoIII resulted in significantly increased levels of DNA damage at 3 and 24 h after the last exposure to 11.5 and 23 mg/kg/day BeCl 2 ( Figure 3) ; digestion with Fpg only resulted in a slight but significant increase in DNA damage and only at the 3-h sampling time with 23 mg/kg/day BeCl 2 (Figure 4 ). These findings suggest that these two lesion-specific endonucleases have some different sensitivity toward BeCl 2 -induced DNA damage and that BeCl 2 predominantly induces DNA lesions more sensitive to EndoIII digestion in bone marrow cells. Thus, oxidative DNA damage induced by BeCl 2 may be one of its genotoxic and carcinogenic modes of action.
To confirm the role of increased oxidative stress in the induction of oxidative DNA damage, quantification of 8-OHdG was performed. Among the various DNA oxidative lesions, 8-OHdG is the most abundant oxidised base generated in vivo by various types of reactive oxygen species. This aberrant base is a pre-mutagenic lesion, inducing G-C to T-A transversions (27) . A substantial body of evidence indicates that 8-OHdG is possibly an important biomarker for oxidative DNA damage in various diseases and ageing process (28, 29) . In this study, at both sampling times higher levels of 8-OHdG were observed after repeated exposures to 11.5 and 23 mg/kg/day BeCl 2 for 7 days ( Figure 5 ). Increased oxidative stress was directly correlated with increased bone marrow DNA strand breaks and MN formation, which further indicated that involvement of oxidative stress and the oxidative DNA damage may be one of the most important factors responsible for the bone marrow genotoxicity induced by BeCl 2 .
In the real-time RT-PCR (Figure 6 ), the expression of some DNA repair-related genes such as OGG1, Apex1 and p53 significantly increased in mice killed after 3 h of the last treatment of BeCl 2 compared with the control animals; however, no significant alterations in the expression of PARP1 and XRCC1 genes was observed. It is noteworthy that the expression of Apex1 and OGG1 was significantly decreased at 24 h after the last exposure to BeCl 2 compared with control, which indicated an inhibition of DNA-damage repair by BeCl 2 . This decrease or suppression of Apex1 and OGG1 may suggest that inhibition of DNA-damage repair may be one of the potential mechanisms for BeCl 2 -induced unrepaired genomic damage that ends up as MN and OTM as observed at 24 h after the last treatment with BeCl 2 . These results are in harmony with the previous in vitro study with BALB 3/T3 cells, in which beryllium caused a down-regulation of genes involved in DNA repair (MCM4, MCM5, Rad23 and DNA ligase I) (30) . Therefore, BeCl 2 may cause DNA damage to bone marrow cells due to the oxidative stress and the induced unrepaired DNA damage is probably due to the alterations in the expression of DNA repair genes.
In conclusion, the results of this study suggest that repeated oral administration of BeCl 2 induces DNA damage that ends up as MN or OTM. The mechanism by which BeCl 2 cause this adverse effect appears related, in part, to the generation of oxidative stress. The higher dose of BeCl 2 at both sampling times gave the more DNA damage and generation of oxidative stress. In general, the response was higher at 3 h after treatment 5 . Levels of 8-OHdG in serum of mice 3 and 24 h after the last treatment with the indicated doses of BeCl 2 (mg/kg/day) (7 days exposures, spaced 24 h apart) (mean ± standard deviation). *P < 0.05 and **P < 0.01 versus the corresponding control (analysis of variance). Fig. 6 . Real-time RT-PCR analysis of mRNA expression of some DNA repair genes in bone marrow of mice 3 and 24 h after the last treatment with the indicated doses of BeCl 2 (mg/kg/day) (7 days exposures, spaced 24 h apart) (mean ± standard error). The values are expressed as a fold of changes. *P < 0.05 and **P < 0.01 versus the corresponding control (unpaired t-test).
than at 24 h, suggesting that there was a time-dependent reduction in DNA damage, which may also suggest a timedependent DNA-damage repair. However, the positive finding of comet assay at 24-h sampling time and MN test suggests that the induced DNA damage is not completely repaired due to the down-regulation of the DNA repair genes at the same time, which may lead to genotoxicity or genomic damage and eventually cause carcinogenicity.
